064 - Pharma and Medical Device Development Processes, DFSS and Design Reviews with Skip Creveling

Let's Combinate · 21 Dec 2022 · 54m

What this episode covers

Skip Creveling, President of PDSS Inc., explains how Design for Six Sigma (DFSS) and Critical Parameter Management integrate into the product development lifecycle of pharma and medical device companies like Merck and Pfizer. He details the CDOV model (Concept, Design, Optimize, Verify), emphasizing the distinction between Necessary, Unique, and Difficult (NUD) parameters and Existing, Common, and Old (ECO) elements to manage risk and complexity. Creveling argues that focusing on NUDs early through robust design and stress testing prevents costly failures, while leveraging ECOS accelerates development. The discussion covers specific tools like the 'Big Seven' checks, robustness optimization, and the cultural shift from rushing to rigorous, data-backed decision-making in regulated industries.

Other shows on the same ground, closest first.

  • Global Medical Device Podcast · 42m

    #382: Design of Experiments - How and When to Use DOE

    Perry Parendo, founder of Perry Solutions, explains how Design of Experiments (DOE) serves as a strategic tool for understanding systems and reducing risk in medical device R&D and manufacturing. He details the practical application of DOE, emphasizing the use of fractional factorial designs to manage 3-7 variables effectively, and warns against common pitfalls like using pass/fail metrics or relying solely on software tutorials without practical training. Parendo advocates for a phased approach—starting with small 'play' experiments, moving to structured DOE, and ending with verification tests—to ensure robust process stability and product performance before validation.

  • Global Medical Device Podcast · 47m

    #461: Why Manufacturing is Part of Product Development with Mike Dolphin

    Mike Dolphin, CEO of GuideStar Medical Devices, explains why manufacturing process development must be integrated into product design rather than treated as a post-development step. He details the engineering of a closed-loop epidural safety device, emphasizing early decisions on injection molding and radiation sterilization to ensure scalability. Dolphin highlights the financial and timeline risks of using contract manufacturers for iterative development, advocating for in-house manufacturing to reduce costs and accelerate FDA 510(k) clearance.

  • Being an Engineer · 48m

    S2E34 How Process Engineering Will Make You An Invaluable Engineer | Zach O’Ferrell

    Zach O’Ferrell, Director of Product and Process Engineering at Edwards Lifesciences, explains how process engineering bridges the gap between product design and manufacturing. He details critical methodologies including DMAIC, Six Sigma, and Lean, as well as the rigorous IQ/OQ/PQ equipment qualification process required in medical device manufacturing. O’Ferrell shares lessons learned from transferring production lines and managing engineering teams, emphasizing a blame-free culture focused on root cause analysis.

  • The Builder Circle · 1h 13m

    S2 E6: Complex System Development with Kristine Barnes

    Kristine Barnes, a hardware engineer with experience at General Motors and in the nuclear power industry, explains how to manage complex system development. She details the importance of requirements flow-down, using DFMEA to identify and mitigate risks, and the dangers of relying on unvalidated CAE models. Barnes advises startups to focus on a single product launch before introducing variety and to balance rigorous engineering processes with the need for speed.

  • Being an Engineer · 53m

    S7E19 Ryan Schoonmaker | How to Take A Structured Approach to Solving Engineering Problems

    Ryan Schoonmaker, founder of Tight Line Solutions and former Director of Mechanical Engineering at Beta Bionics, Dexcom, and BD, explains how to bring structure to chaotic product development. He emphasizes that successful execution requires clear requirements, robust assembly specifications, and early decisions on critical elements like component colors to avoid regulatory delays. Schoonmaker draws on his experience with the Dexcom G6 and G7 to illustrate how narrowing down system failures and managing technical debt differently at startups versus large enterprises leads to predictable outcomes.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Let's Combinate. The episode itself belongs to its publisher.